Alliance Pharma (LON:APH) Downgraded to Hold Rating by Berenberg Bank

Berenberg Bank downgraded shares of Alliance Pharma (LON:APH) to a hold rating in a research report released on Wednesday morning, Marketbeat reports. They currently have GBX 6,250 ($77.46) target price on the stock, down from their previous target price of GBX 7,000 ($86.75).

Alliance Pharma Stock Up 0.2 %

Shares of Alliance Pharma stock opened at GBX 61.30 ($0.76) on Wednesday. The company’s 50 day moving average price is GBX 50.60 and its 200-day moving average price is GBX 44.36. Alliance Pharma has a 52-week low of GBX 24.55 ($0.30) and a 52-week high of GBX 61.60 ($0.76). The company has a debt-to-equity ratio of 47.46, a quick ratio of 1.42 and a current ratio of 2.93. The stock has a market capitalization of £331.37 million, a price-to-earnings ratio of -1,021.67, a P/E/G ratio of 1.04 and a beta of 0.67.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.